MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
FDA _ Accelerated Approval
DizalPharma
Organization & Developments: DizalPharma
Parents
DizalPharma
Children
2025: Dizal’s ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Jumps
Finance & Acquisition: DizalPharma
Key People: DizalPharma